ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,488Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 1006

$615K Total Retail Price of All Prescriptions

Rank: 146 out of 1006

340 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 8,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 557 453 1 3
SIMVASTATIN 443 337 2 1
METFORMIN HCL 399 301 3 10
CRESTOR 340 240 4 18
AMLODIPINE BESYLATE 332 289 5 4
LEVOTHYROXINE SODIUM 299 233 6 2
OMEPRAZOLE 288 172 7 9
FUROSEMIDE 278 239 8 6
NEXIUM 274 221 9 28
ATORVASTATIN CALCIUM 211 161 10 5
HYDROCHLOROTHIAZIDE 209 176 11 11
MELOXICAM 173 144 12 67
METOPROLOL TARTRATE 170 142 13 7
DIOVAN 169 128 14 16
ZOLPIDEM TARTRATE 167 147 15 14
TRAMADOL HCL 145 114 16 35
PROAIR HFA 137 109 17 64
CITALOPRAM HBR 119 91 18 24
TRAZODONE HCL 113 93 19 21
PANTOPRAZOLE SODIUM 110 75 20 32
ALENDRONATE SODIUM 108 99 21 29
GLIMEPIRIDE 102 64 22 50
GABAPENTIN 98 67 23 20
LOSARTAN POTASSIUM 92 84 24 22
SINGULAIR 91 71 25 82
METOPROLOL SUCCINATE 91 79 25 12
ADVAIR DISKUS 88 79 27 37
VENTOLIN HFA 88 57 27 161
LIPITOR 87 79 29 47
DONEPEZIL HCL 86 86 30 17
TAMSULOSIN HCL 83 83 31 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 57 32 38
PRAVASTATIN SODIUM 81 73 32 15
HYDROCODONE-ACETAMINOPHEN 80 57 S3 34 25
CLOPIDOGREL 79 69 35 46
OXYCODONE-ACETAMINOPHEN 79 51 S2 35 57
JANUVIA 78 64 37 49
ATENOLOL 77 60 38 13
GLYBURIDE 72 67 R 39 65
LOVASTATIN 69 49 40 44
DEXILANT 68 43 41 142
LANTUS SOLOSTAR 66 50 42 93
CARVEDILOL 65 58 43 36
IBUPROFEN 64 38 44 114
LANTUS 64 51 44 43
AZITHROMYCIN 63 45 46 39
MONTELUKAST SODIUM 62 45 47 125
PLAVIX 59 51 48 61
ACTOS 58 38 49 89
WARFARIN SODIUM 57 53 50 8
NAPROXEN 54 46 51 121
POTASSIUM CHLORIDE 51 47 52 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.